Insmed announces closing of public offerings of common stock and convertible senior notes and full exercise of underwriters' options to purchase additional shares and notes

Bridgewater, n.j., may 13, 2021 /prnewswire/ -- insmed incorporated (nasdaq: insm) announced today the closing of the previously announced registered underwritten public offering (the "equity offering") of 11,500,000 shares of its common stock (the "shares"), including 1,500,000 shares issued pursuant to the exercise in full of the underwriters' option to purchase additional shares, at a price to the public of $25.00 per share before deducting underwriting discounts and commissions, and the previously announced registered underwritten public offering (the "notes offering") of $575 million aggregate principal amount of its 0.75% convertible senior notes due 2028 (the "notes"), including $75 million aggregate principal amount of notes purchased pursuant to the exercise in full of the underwriters' option to purchase additional notes, solely to cover over-allotments.
INSM Ratings Summary
INSM Quant Ranking